GlassScriptPhysician profile
Pranay Korpole
NPI 1538553433
$5,097.25
in general payments reported to CMS, 2019-2025
20 companies · $3,069 in 2025
The $3,069 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $842 · 2023: $740 · 2024: $287 · 2025: $3,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,595.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,500.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $527.06 | 2021-2025 | Fasenra |
| Glaxosmithkline, LLC. | $442.34 | 2022-2025 | Nucala, Trelegy Ellipta |
| Zoll Respicardia, INC. | $412.12 | 2025 | Remede System |
| United Therapeutics Corporation | $256.80 | 2022-2024 | Tyvaso |
| Grifols USA, LLC | $155.02 | 2023 | Prolastin-C Liquid |
| Genzyme Corporation | $130.53 | 2023 | |
| Axsome Therapeutics, INC. | $124.31 | 2023 | Sunosi |
| Gilead Sciences, INC. | $119.70 | 2022 | |
| Janssen Pharmaceuticals, INC | $109.62 | 2024 | Xarelto |
| Abiomed | $87.76 | 2023 | Impella |
| Edwards Lifesciences Corporation | $48.26 | 2022-2024 | Hemosphere |
| Baxter Healthcare | $30.41 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Actelion Pharmaceuticals US, INC. | $27.06 | 2024 | Opsumit |
| Jazz Pharmaceuticals INC. | $26.82 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $23.18 | 2025 | Dupixent |
| Alexion Pharmaceuticals, INC. | $21.87 | 2025 | Ultomiris |
| Paratek Pharmaceuticals, INC. | $19.91 | 2021 | |
| Bard Peripheral Vascular, INC. | $19.44 | 2023 | |
| Insmed, INC. | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranay Korpole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.